Literature DB >> 7844071

Pharmacokinetics and prescribing in the elderly.

C G Swift1.   

Abstract

The use of prescribed medication in general is higher in the elderly than in the young and it is possible that existing patterns of antimicrobial agent prescribing may predispose to suboptimal response, certain adverse drug reactions (ADR) and the emergence of resistant strains of organisms. Age is an important variable affecting the pharmacokinetics of drugs, including many antimicrobials. Changes which may affect Cmax/MIC ratios and/or the time above MIC include reduced first-pass metabolism, altered distribution volume, reduced binding to albumin, reduced metabolic biotransformation and reduced renal elimination. Application of a knowledge of antimicrobial agent pharmacokinetic changes with age and their implications for response may enable more precise determination of dose regimens for older patients, which is probably desirable for the prevention of both ADR and bacterial resistance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7844071     DOI: 10.1093/jac/34.suppl_a.25

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 2.  Streptogramins and their potential role in geriatric medicine.

Authors:  B M Lomaestro; L L Briceland
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

3.  Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.

Authors:  F J Legat; A Maier; P Dittrich; P Zenahlik; T Kern; S Nuhsbaumer; M Frossard; W Salmhofer; H Kerl; M Müller
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia.

Authors:  Noriyuki Ishihara; Nobuhiro Nishimura; Kazuro Ikawa; Fumi Karino; Kiyotaka Miura; Hiroki Tamaki; Takahisa Yano; Takeshi Isobe; Norifumi Morikawa; Kohji Naora
Journal:  Antibiotics (Basel)       Date:  2020-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.